Skip to main content Accessibility help
×
Hostname: page-component-84b7d79bbc-7nlkj Total loading time: 0 Render date: 2024-07-26T12:22:46.416Z Has data issue: false hasContentIssue false

Stiripentol

Published online by Cambridge University Press:  04 August 2010

Philip N. Patsalos
Affiliation:
Chalfont Centre for Epilepsy, Buckinghamshire, UK
Blaise F. D. Bourgeois
Affiliation:
Harvard Medical School, Boston
Get access
Type
Chapter
Information
Publisher: Cambridge University Press
Print publication year: 2010

Access options

Get access to the full version of this content by using one of the access options below. (Log in options will check for institutional or personal access. Content may require purchase if you do not have access.)

References

Cazali, N, Tran, A, Treluyer, JM, Rey, E, d'Athis, P, Vincent, J, Pons, G. Inhibitory effect of stiripentol on carbamazepine and saquinavir metabolism in human. British Journal of Clinical Pharmacology 2003; 56: 526–536.CrossRefGoogle ScholarPubMed
Chiron, C. Stiripentol. Neurotherapeutics 2007; 4: 123–125.CrossRef
Chiron, C, Marchand, MC, Tran, A, d'Athis, P, Vincent, J, Dulac, O, Pons, G. Stiripentol in severe myoclonic epilepsy in infancy: a randomised placebo-controlled syndrome-dedicated trial. STICLO study group. Lancet 2000; 356: 1638–1642.CrossRefGoogle ScholarPubMed
Chiron, C, Tonnelier, S, Rey, E, Brunet, ML, Tran, A, d'Athis, P, Vincent, J, Dulac, O, Pons, G. Stiripentol in childhood partial epilepsy: randomized placebo-controlled trial with enrichment and withdrawal design. Journal of Child Neurology 2006; 21: 496–502.CrossRefGoogle ScholarPubMed
Giraud, C, Treluyer, JM, Rey, E, Chiron, C, Vincent, J, Pons, G, Tran, A. In vitro and in vivo inhibitory effect of stiripentol on clobazam metabolism. Drug Metabolism and Disposition 2006; 34: 608–611.CrossRefGoogle ScholarPubMed
Kassai, B, Chiron, C, Augier, S, Cucherat, M, Rey, E, Gueyffier, F, Guerrini, R, Vincent, J, Dulac, O, Pons, G. Severe myoclonic epilepsy in infancy: a systematic review and meta-analysis of individual patient data. Epilepsia 2008; 49: 343–348.CrossRefGoogle ScholarPubMed

Save book to Kindle

To save this book to your Kindle, first ensure coreplatform@cambridge.org is added to your Approved Personal Document E-mail List under your Personal Document Settings on the Manage Your Content and Devices page of your Amazon account. Then enter the ‘name’ part of your Kindle email address below. Find out more about saving to your Kindle.

Note you can select to save to either the @free.kindle.com or @kindle.com variations. ‘@free.kindle.com’ emails are free but can only be saved to your device when it is connected to wi-fi. ‘@kindle.com’ emails can be delivered even when you are not connected to wi-fi, but note that service fees apply.

Find out more about the Kindle Personal Document Service.

Available formats
×

Save book to Dropbox

To save content items to your account, please confirm that you agree to abide by our usage policies. If this is the first time you use this feature, you will be asked to authorise Cambridge Core to connect with your account. Find out more about saving content to Dropbox.

Available formats
×

Save book to Google Drive

To save content items to your account, please confirm that you agree to abide by our usage policies. If this is the first time you use this feature, you will be asked to authorise Cambridge Core to connect with your account. Find out more about saving content to Google Drive.

Available formats
×